Skip to content

Clinical trials

Terminated Breast Neoplasms trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Terminated Country / region: Hungary Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20081
20092
20102
20122
20141
20172
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
ETOP IBCSG Partners Foundation2
Novartis Pharmaceuticals2
Amgen1
Central European Cooperative Oncology Group1
Eli Lilly and Company1
NSABP Foundation Inc1
Odonate Therapeutics, Inc.1
Sanofi1
Tesaro, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms14
Neoplasm Metastasis2
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Ovarian Epithelial1
Hereditary Sensory and Autonomic Neuropathies1
Ovarian Neoplasms1
Recurrence1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.